The estimated Net Worth of John G. Nackel is at least $7.33 Million dollars as of 17 May 2024. John Nackel owns over 57,613 units of Pennant Inc stock worth over $5,220,009 and over the last 16 years he sold PNTG stock worth over $1,994,386. In addition, he makes $110,731 as Independent Director at Pennant Inc.
John has made over 31 trades of the Pennant Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 57,613 units of PNTG stock worth $235,637 on 17 May 2024.
The largest trade he's ever made was exercising 57,613 units of Pennant Inc stock on 17 May 2024 worth over $235,637. On average, John trades about 1,549 units every 45 days since 2008. As of 17 May 2024 he still owns at least 155,265 units of Pennant Inc stock.
You can see the complete history of John Nackel stock trades at the bottom of the page.
Dr. John G. Nackel Ph.D. serves as Independent Director of the Company. He served as a member of the board of directors of Ensign from June 2008 through December 2019. He is currently the Chairman and Chief Executive Officer of Three-Sixty Advisory Group, LLC (“Three-Sixty”) and Founder and General Partner of Wavemaker Three-Sixty Health, LP (“Wavemaker 360”) venture fund. Founded in 2007 by Dr. Nackel, Three-Sixty consults with leading health systems, payers, physicians, medical technology companies, and other providers. Founded in 2018, Wavemaker 360 invests in early-stage health care companies in the value-based payment space. Dr. Nackel is a 25-year veteran of Ernst & Young where he advised health care companies in his role as a Global Managing Director of Health Care. Dr. Nackel also served as Chief Executive Officer of Ingenix Consulting (now Optum), a division of United Healthcare. In addition, Dr. Nackel served as a director of Mercury General Corporation (NYSE: MCY) from 2016 until 2018. During his career, Dr. Nackel has also served as a board member or chairman of several privately held start-ups and emerging companies, including Visual Health Solutions, Vitalacy, HealthTask, ConnectedHealth, NetStrike, and Sertan, Inc. He earned his bachelor’s degree at Tufts University, master’s degrees in public health and industrial engineering at the University of Missouri, and a Ph.D. in industrial engineering (health systems design) at the University of Missouri. He is a fellow of the American College of Healthcare Executives and the Healthcare Information and Management Systems Society. He is a senior member of the Institute of Industrial Engineers.
As the Independent Director of Pennant Inc, the total compensation of John Nackel at Pennant Inc is $110,731. There are 4 executives at Pennant Inc getting paid more, with Daniel Walker having the highest compensation of $18,278,600.
John Nackel is 68, he's been the Independent Director of Pennant Inc since 2019. There are no older and 9 younger executives at Pennant Inc.
John's mailing address filed with the SEC is C/O THE PENNANT GROUP, INC., 1675 EAST RIVERSIDE DRIVE, SUITE 150, EAGLE, ID, 83616.
Over the last 5 years, insiders at Pennant Inc have traded over $12,637,048 worth of Pennant Inc stock and bought 92,617 units worth $1,362,024 . The most active insiders traders include Christopher R. Christensen, Scott E Lamb, and Roderic W Lewis. On average, Pennant Inc executives and independent directors trade stock every 44 days with the average trade being worth of $406,970. The most recent stock trade was executed by Brent Guerisoli on 27 August 2024, trading 2,515 units of PNTG stock currently worth $18,661.
cornerstone service center, inc. supports the companies of cornerstone healthcare, inc. (which is itself a subsidiary of the ensign group, inc. - nasdaq ensg). cornerstone healthcare, inc. focuses on acquiring, operating, and expanding home health, hospice and private duty companies in the united states with current operations in california, oregon, washington, idaho, utah, arizona, colorado, texas & iowa.
Pennant Inc executives and other stock owners filed with the SEC include: